| Literature DB >> 29898143 |
George Samanidis1, Charalampos Katselis1, Constantinos Contrafouris1, Georgios Georgiopoulos2, Ioannis Kriaras3, Theofani Antoniou4, Konstantinos Perreas1.
Abstract
INTRODUCTION: Hypothermic circulatory arrest is widely used for correction of acute type A aortic dissection pathology. We present our experience of 45 consecutive patients operated in our unit with bilateral antegrade cerebral perfusion and moderate hypothermic circulatory arrest.Entities:
Mesh:
Year: 2018 PMID: 29898143 PMCID: PMC5985840 DOI: 10.21470/1678-9741-2017-0123
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Baseline demographic and preoperative data.
| Preoperative data | No. of patients |
|---|---|
| Sex | |
| Male | 34 (75.6) |
| Female | 11 (24.4) |
| Age (years) | 58±11.4 |
| Mean body surface area (m2) | 2±0.24 |
| Preoperative creatinine plasma (mg/dL), median (IQR) | 0.9 (0.8-1.3) |
| Preoperative hemodynamic instability | 7 (15.6) |
| Previous cardiac surgery operation | 2 (4.4) |
| Preoperative NT-proBNP (pg/mL), median (IQR) | 247 (114-816) |
| Preoperative D-dimer (µg/L), median (IQR) | 6503 (3418-8610) |
Data are presented as mean ± SD or median (IQR) for continuous variables and as number and percentage for categorical variables.
IQR=interquartile range; NT-proBNP=N-terminal prohormone of brain natriuretic peptide; SD=standard deviation
Perioperative data.
| Perioperative data | No. of patients Total n=45 (%) |
|---|---|
| Combined operations | 12 (26.7) |
| Types of operations | |
| Interposition graft replacement | 29 (64.4) |
| Interposition graft replacement + modified Bentall operation | 5 (11.1) |
| Interposition graft replacement + aortic valve replacement | 3 (6.7) |
| Interposition graft replacement + coronary bypass grafting | 2 (4.4) |
| Interposition graft replacement + aortic arch replacement | 6 (13.3) |
| Total circulatory arrest time (min), median (IQR) | 41.5 (30-54) |
| Aortic cross-clamp time (min), median (IQR) | 107 (92-130) |
| Cardiopulmonary bypass time (min), median (IQR) | 211 (184-240) |
| Bladder temperature during circulatory arrest (ºC), median (IQR) | 22.3 (20.8-24) |
| pH during circulatory arrest, median (IQR) | 7.33 (7.29-7.35) |
Data are presented as mean ± SD or median (IQR) for continuous variables and as number and percentage for categorical variables.
IQR=interquartile range; SD=standard deviation
Postoperative complications and follow-up data.
| Postoperative complications and follow-up data | No. of Patients Total n=45 (%) |
|---|---|
| Atrial fibrillation | 11 (24.4) |
| Permanent pacemaker | 2 (4.4) |
| Pericardial effusion | 5 (11.1) |
| Mechanical ventilation > 48 hours in intensive care unit | 29 (64.4) |
| Postoperative open sternum | 14 (31.1) |
| Postoperative acute kidney injury (increase postoperative >50 % of preoperative creatinine plasma) | 23 (51.1) |
| Postoperative neurological dysfunction: | |
| No neurological dysfunction | 36 (80) |
| Temporary neurological dysfunction | ___ |
| Permanent neurological dysfunction | 6 (13.3) |
| Heavy neurological dysfunction | 3 (6.7) |
| Postoperative transfusion of red blood cells (unit), median (range) | 10 (2-38) |
| Postoperative transfusion of fresh frozen plasma (unit), median (range) | 8 (3-36) |
| Postoperative creatinine plasma (mg/dL), median (IQR) | 1.6 (1.3-2.3) |
| Postoperative stay in ICU (days), median (IQR) | 8 (3-9) |
| Postoperative in-hospital stay (days), median (IQR) | 12 (8-18) |
| Follow-up (months), median (IQR) | 6 (2-12) |
| Overall mortality | 6 (13.3) |
| 30-days mortality | 3 (6.7) |
| All cause deaths during median follow-up 6 (2-12) months | 3 (6.7) |
Data are presented as mean ± SD or median (IQR) for continuous variables and as number and percentage for categorical variables.
Permanent neurological dysfunction (PND)=hemiplegia or paraplegia >48 hours after discharge at home. Heavy neurological deficits=diffuse and irreversible brain damage or coma.
ICU=intensive care unit; IQR=interquartile range
Univariate risk factors for 30-day mortality.
| Variable | No. of patients | 30-day mortality | OR | 95% CI | |
|---|---|---|---|---|---|
| Overall | 45 | 3 (6.7) | |||
| Preoperative factors | |||||
| Age (years) | 58±11.4 | 0.909 | (0.805-1.01) | 0.071 | |
| Sex (female) | 11 (26.19) | __ | 0.775 | (0-7.7) | 0.565 |
| Preoperative hemodynamic instability | 7 (15.6) | 2 (4.4) | 14.8 | (2.41-90.6) | 0.004 |
| Preoperative D-dimer | 1.001 | (0.999-1.001) | 0.798 | ||
| Preoperative NT-proBNP | 1.002 | (0.999-1.001) | 0.658 | ||
| Perioperative factors | |||||
| Arterial cannulation site (femoral artery) | 3 (6.7) | __ | 3.74 | (0-44.3) | 0.999 |
| Total aortic arch replacement | 7 (15.6) | __ | 1.39 | (0.14-15.9) | 0.999 |
| Combined operation | 12 (26.7) | __ | 0.687 | (0-6.8) | 0.554 |
| Cardiopulmonary bypass time | 0.991 | (0.955-1.019) | 0.581 | ||
| Aortic cross-clamp time | 0.986 | (0.933-1.028) | 0.584 | ||
| Total circulatory arrest time | 0.957 | (0.853-1.029) | 0.374 | ||
| Bladder temperature during circulatory arrest | 1.29 | (0.829-2.01) | 0.227 | ||
| Postoperative factors | |||||
| Postoperative open sternum | 14 (31.1) | 2 (4.4) | 5 | (1.041-24.0) | 0.044 |
| Postoperative pericardial effusion | 5 (11.1) | __ | 2.07 | (0-22) | 0.999 |
| Postoperative atrial fibrillation | 11 (24.4) | __ | 0.775 | (0-7.7) | 0.565 |
| Postoperative stay in ICU | 0.581 | (0.299-1.127) | 0.108 |
P-values are derived from exact univariate logistic regression.
Confidence intervals are derived from bootstrapping with 1000 replications.
NT-proBNP=N-terminal prohormone of brain natriuretic peptide; ICU=intensive care unit
Univariate risk factors for postoperative severe neurological complication.
| Variable | No. of patients | Postoperative neurological complication | OR | 95% CI | |
|---|---|---|---|---|---|
| Overall | 45 (100.0) | ||||
| Preoperative factors | |||||
| Age (years) | 58±11.4 | 0.977 | (0.915-1.042) | 0.489 | |
| Sex (female) | 11 (26.19) | 1 (2.2) | 0.338 | (0.007-3.1) | 0.416 |
| Reoperation | 2 (4.4) | __ | 1.64 | (0-22) | 0.999 |
| Preoperative hemodynamic instability | 7 (15.6) | 4 (8.9) | 8.8 | (1.41-54.9) | 0.02* |
| Preoperative NT-proBNP | 0.999 | (0.999-1.001) | 0.621 | ||
| Perioperative factors | |||||
| Arterial cannulation site (common carotid artery with graft) | 42 (93.3) | 8 (17.8) | 0.480 | (0.022-31) | 0.999 |
| Arterial cannulation site (femoral artery) | 3 (6.7) | 1 (2.2) | 2.13 | (0.426-10.6) | 0.358 |
| Total aortic arch replacement | 7 (15.6) | 2 (4.4) | 1.75 | (0.139-13.8) | 0.614 |
| Combined operation | 12 (26.7) | 2 (4.4) | 0.748 | (0.065-4.93) | 0.999 |
| Cardiopulmonary bypass time | 1.002 | (0.985-1.018) | 0.805 | ||
| Aortic cross-clamp time | 1.01 | (0.981-1.029) | 0.673 | ||
| Total circulatory arrest time | 1.01 | (0.974-1.037) | 0.686 | ||
| Bladder temperature during circulatory arrest | 1.33 | (0.980-1.86) | 0.058* | ||
| Postoperative factors | |||||
| Postoperative open sternum | 14 (31.1) | 3 (6.7) | 1.13 | (0.155-6.6) | 0.999 |
| Postoperative acute kidney injury | 23 (51.1) | 6 (13.3) | 2.2 | (0.394-15.7) | 0.459 |
| Postoperative pericardial effusion | 5 (11.1) | 1 (2.2) | 1 | (0.018-12.2) | 0.999 |
| Postoperative permanent pacemaker implantation | 2 (4.4) | __ | 1.64 | (0-22) | 0.999 |
| Postoperative atrial fibrillation | 11 (24.4) | 3 (6.7) | 1.73 | (0.228-10.6) | 0.666 |
| Postoperative sepsis or multiple organ dysfunctions | 6 (13.3) | 4 (8.9) | 13.6 | (2.1-89.9) | 0.007* |
| Postoperative stay in ICU | 1.040 | (0.966-1.12) | 0.254 | ||
| Postoperative hospital stay | 1.031 | (0.982-1.1) | 0.180 |
P-values are derived from exact univariate logistic regression.
Confidence intervals are derived from bootstrapping with 1000 replications.
NT-proBNP=N-terminal prohormone of brain natriuretic peptide; ICU=intensive care unit
Multivariable logistic regression analysis for the main determinants of the incidence of postoperative severe neurological outcome (n=45).
| Variable | OR | 95% CI | |
|---|---|---|---|
| Bladder temperature during circulatory arrest | 1.28 | 0.885-1.89 | 0.183 |
| Preoperative hemodynamic instability | 5.5 | 0.454-77 | 0.221 |
| Postoperative sepsis or multiple organ dysfunction | 15.9 | 1.05-96.4 | 0.045* |
P-values are derived from exact logistic regression.
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| AAD | = Acute type A aortic dissection | HTK | = Histidine-tryptophan-ketoglutarate | |
| ACP | = Antegrade cerebral perfusion | ICU | = Intensive care unit | |
| AF | = Atrial fibrillation | MHCA/BACP | = Moderate hypothermic circulatory arrest and bilateral antegrade cerebral perfusion | |
| BACP | = Bilateral antegrade cerebral perfusion | MHCA/UACP or BACP | = Moderate hypothermic circulatory arrest with unilateral or bilateral cerebral perfusion | |
| CA | = Circulatory arrest | PND | = Permanent neurological dysfunctions | |
| CCA | = Common carotid artery | RCP | = Retrograde cerebral perfusion | |
| CNS | = Central nervous system | TIA | = Transient ischemic attack | |
| CPB | = Cardiopulmonary bypass | TND | = Temporary neurological dysfunctions | |
| CT | = Computed tomography | UACP | = Unilateral antegrade cerebral perfusion | |
| DHCA | = Deep hypothermic circulatory arrest | |||
| DHCA/UACP or BACP | = Deep hypothermic circulatory arrest with unilateral or bilateral cerebral perfusion | |||
| Authors' roles & responsibilities | |
|---|---|
| GS | Took part in the care of the patients and contributed equally in data collection and manuscript preparation; final approval of the version to be published |
| CK | Took part in the care of the patients and contributed equally in data collection and manuscript preparation; final approval of the version to be published |
| CC | Took part in the care of the patients and contributed equally in data collection and manuscript preparation; final approval of the version to be published |
| GG | Contributed in the statistical analysis of the data; final approval of the version to be published |
| IK | Took part in the care of the patients and contributed equally in data collection and manuscript preparation; final approval of the version to be published |
| TA | Took part in the care of the patients and contributed equally in data collection and manuscript preparation; final approval of the version to be published |
| KP | Supervision of this report; final approval of the version to be published |